More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure ...

Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...

Impaired mitophagy and the accumulation of damaged mitochondria are key drivers of endothelial cell (EC)dysfunction in ...

Case study presented highlighted clinical experience with revyve® in complex wound care. WINNIPEG, Manitoba, May 13, 2026 ...

Wound healing is a highly dynamic and complex biological process involving multiple overlapping phases, including inflammation, proliferation, and tissue ...

Dermatologists swear by it.

Breakthrough in diabetic wounds: A new mitochondrial therapy accelerates healing in diabetic chronic wounds by restoring endothelial cell function through targeted delivery. Innovative delivery system ...

Sanara MedTech delivered a strong Q1'26, with 19% revenue growth, 93%+ gross margins, and its first GAAP profit in years.

Scientists at Texas A&M College of Veterinary Medicine and Biomedical Sciences have successfully regenerated skeletal and ...

Advanced materials science sits at the intersection of biology, chemistry, and engineering. Recombinant spider silk is ...

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions ("AVITA Medical," or ...

Q1 2026 revenues were $9.6 million, up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history. Q1 2026 gross margin was 77.3%, versus 79.0% in Q1 2025.